Activist investor White Tale on Monday demanded three seats on Clariant’s board and an independent strategic review of the Swiss speciality chemicals group after thwarting its plans to merge with U.S. peer Huntsman in a $20 billion deal.
ZURICH (Reuters) – Activist investor White Tale on Monday demanded three seats on Clariant&rsquo-s board and an independent strategic review of the Swiss speciality chemicals group after thwarting its plans to merge with U.S. peer Huntsman in a $20 billion deal.
&ldquo-Should we be unable to come to agreement with the current board of directors shortly, we will have no choice but to move to call an extraordinary general meeting so that all shareholders can have a voice in Clariant&rsquo-s future,&rdquo- the activist that holds a stake of more than 20 percent said.
0 comments
Share
